255 related articles for article (PubMed ID: 2871486)
21. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
Sinclair NR
CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
[TBL] [Abstract][Full Text] [Related]
24. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
[No Abstract] [Full Text] [Related]
25. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
26. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
27. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
Gruber SA; Pescovitz MD; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Fryd DS
Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
[TBL] [Abstract][Full Text] [Related]
28. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
[TBL] [Abstract][Full Text] [Related]
29. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
[No Abstract] [Full Text] [Related]
30. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
33. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
34. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
Schulak JA; Mayes JT; Moritz CE; Hricik DE
Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Hesse UJ; Fryd DS; Chatterjee SN; Simmons RL; Sutherland DE; Najarian JS
Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
[TBL] [Abstract][Full Text] [Related]
36. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry M; Ferguson RM
Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
[TBL] [Abstract][Full Text] [Related]
37. Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation.
So SK; Najarian JS; Nevins TE; Fryd DS; Knaak M; Chavers B; Mauer SM; Simmons RL
J Pediatr; 1987 Dec; 111(6 Pt 2):1017-21. PubMed ID: 3316573
[TBL] [Abstract][Full Text] [Related]
38. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
Hall BM; Tiller DJ; Duggin GG; Horvath JS; Farnsworth A; May J; Johnson JR; Sheil AG
Kidney Int; 1985 Aug; 28(2):178-86. PubMed ID: 3914572
[TBL] [Abstract][Full Text] [Related]
39. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
Sutherland DE; Strand M; Fryd DS; Ferguson RM; Simmons RL; Ascher NL; Najarian JS
Am J Kidney Dis; 1984 May; 3(6):456-61. PubMed ID: 6372449
[No Abstract] [Full Text] [Related]
40. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
